Epitomee Medical Ltd (TLV: EPIT)

Epitomee Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	2.66	-5.68	-15.39
Depreciation & Amortization	0.47	0.64	0.36
Loss (Gain) From Sale of Assets	-	0.06	-
Asset Writedown & Restructuring Costs	0.15	7.18	-
Stock-Based Compensation	0.72	0.99	1.54
Other Operating Activities	-2.03	-1	4.38
Change in Accounts Receivable	0.05	0.05	0.17
Change in Accounts Payable	0.43	0.24	-0.83
Change in Unearned Revenue	-10	-10	-
Change in Other Net Operating Assets	-0.06	-0.4	0.36
Operating Cash Flow	-7.53	-7.92	-9.42
Capital Expenditures	-4.46	-4.07	-3.7
Investment in Securities	9.22	-9.01	-9.59
Other Investing Activities	1.54	0.86	0.17
Investing Cash Flow	6.31	-12.22	-13.12
Long-Term Debt Repaid	-	-0.5	-0.33
Net Debt Issued (Repaid)	-0.48	-0.5	-0.33
Issuance of Common Stock	0.02	0.04	-
Financing Cash Flow	-0.46	-0.45	-0.33
Foreign Exchange Rate Adjustments	0.24	0.28	-5.49
Net Cash Flow	-1.45	-20.32	-28.36
Free Cash Flow	-11.99	-12	-13.12
Free Cash Flow Margin	-119.87%	-119.96%	-
Free Cash Flow Per Share	-0.39	-0.40	-0.45
Levered Free Cash Flow	1.46	-2.28	-
Unlevered Free Cash Flow	1.46	-2.24	-
Change in Net Working Capital	0.45	0.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.